Effect of pioglitazone preconditioning on quantity and function of bone marrow-derived endothelial progenitor cells in spontaneously hypertensive rats

陆庆明,邸春霞,王海昌,张荣庆
2008-01-01
Abstract:Background: Peroxisome proliferators-activated receptor gamma can up-regulate endothelial progenitor cells (EPCs). Objective: To investigate the effect of pioglitazone on quantity and function of bone marrow-derived EPCs of in vitro cultured rats with spontaneously hypertensive. Design, time and setting: The randomized control animal study was performed at State Key Laboratory of Department of Cardiology, Xijing Hospital, Fourth Military Medical University of Chinese PLA from May to August 2007. Materials: Twenty clean spontaneously hypertensive and Wistar-Kyoto (WKY) rats were selected each, who had matched age and body mass. Methods: Spontaneously hypertensive and WKY rats were respectively randomized into a drug group and a control group, with 10 rats in each group and received pioglitazone (20 mg/kg d) or saline for 14 days. Systolic pressure of the tail artery in each rat was measured at days 1 and 14 in both groups. Mononuclear cells were harvested from rat bone marrow by density gradient centrifugation. Adherent cells were collected by differential velocity adherent technique. Main outcome measures: EPC quantity; Proliferative activity and nitric oxide levels in EPCs were identified by MTT. Results: There was no significant difference in EPC quantity, proliferation and nitric oxide secretion in WKY rats after treatment of pioglitazone. Pioglitazone significantiy increased EPC quantity, proliferation and nitric oxide secretion in spontaneously hypertensive rats (P < 0.01, P < 0.05, P < 0.01). Conclusion: Pioglitazone up-regulates bone marrow-derived EPC number, and protects EPCs by promoting EPC proliferation and nitric oxide secretion.
What problem does this paper attempt to address?